For research use only
| Cat No. | ABC-TC3214 |
| Product Type | Mouse Primary Cells |
| Cell Type | Endothelial |
| Species | C57BL/6 Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Normal |
| Storage | Liquid Nitrogen |
C57BL/6 Mouse Lung Microvascular Endothelial Cells, isolated from pathogen-free mice, ideal for lung vascular research, endothelial, and disease modeling.
C57BL/6 Mouse Lung Microvascular Endothelial Cells are isolated from pathogen-free adult C57BL/6 mice, commonly used in biomedical research. These cells are derived from lung tissue and are vital for maintaining blood-brain barrier function, essential for substance exchange and protecting cardiovascular, metabolic, and pulmonary health. These cells are cryopreserved at early passage. Morphologically, they exhibit a typical endothelial phenotype with cobblestone-like confluence. They express endothelial markers like VE-cadherin and CD31. These cells are used in models of ARDS, pneumonia, and pulmonary edema. As primary mouse endothelial cells, these cultures also support studies of microvascular endothelial dysfunction, particularly in lung injury and vascular pathology models.
| Species | C57BL/6 Mouse |
| Cat.No | ABC-TC3214 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Endothelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Primary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Mouse models, particularly C57BL/6 primary lung microvascular endothelial cells (LMVECs), serve as a powerful tool for studying endothelial dysfunction—a shared mechanism in diseases like hypertension, diabetes, atherosclerosis, and lung injury. These cells enable researchers to investigate key vascular processes, including tube formation, cell adhesion, migration, and transendothelial resistance, providing critical insights into disease mechanisms and potential therapeutic targets. Their use enhances our understanding of endothelial-related pathologies and supports preclinical drug development.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).